Literature DB >> 35647668

Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo.

Arundhati Gupta1,2, Shana M Owens1,2, Darby G Oldenburg3, Douglas W White3, J Craig Forrest1,2,4.   

Abstract

Gammaherpesviruses (GHVs) are lymphotropic tumor viruses with a biphasic infectious cycle. Lytic replication at the primary site of infection is necessary for GHVs to spread throughout the host and establish latency in distal sites. Dissemination is mediated by infected B cells that traffic hematogenously from draining lymph nodes to peripheral lymphoid organs, such as the spleen. B cells serve as the major reservoir for viral latency, and it is hypothesized that periodic reactivation from latently infected B cells contributes to maintaining long-term chronic infection. While fundamentally important to an understanding of GHV biology, aspects of B cell infection in latency establishment and maintenance are incompletely defined, especially roles for lytic replication and reactivation in this cell type. To address this knowledge gap and overcome limitations of replication-defective viruses, we generated a recombinant murine gammaherpesvirus 68 (MHV68) in which ORF50, the gene that encodes the essential immediate-early replication and transcription activator protein (RTA), was flanked by loxP sites to enable conditional ablation of lytic replication by ORF50 deletion in cells that express Cre recombinase. Following infection of mice that encode Cre in B cells with this virus, splenomegaly and viral reactivation from splenocytes were significantly reduced; however, the number of latently infected splenocytes was equivalent to WT MHV68. Despite ORF50 deletion, MHV68 latency was maintained over time in spleens of mice at levels approximating WT, reactivation-competent MHV68. Treatment of infected mice with lipopolysaccharide (LPS), which promotes B cell activation and MHV68 reactivation ex vivo, yielded equivalent increases in the number of latently infected cells for both ORF50-deleted and WT MHV68, even when mice were simultaneously treated with the antiviral drug cidofovir to prevent reactivation. Together, these data demonstrate that productive viral replication in B cells is not required for MHV68 latency establishment and support the hypothesis that B cell proliferation facilitates latency maintenance in vivo in the absence of reactivation. IMPORTANCE Gammaherpesviruses establish lifelong chronic infections in cells of the immune system and place infected hosts at risk for developing lymphomas and other diseases. It is hypothesized that gammaherpesviruses must initiate acute infection in these cells to establish and maintain long-term infection, but this has not been directly tested. We report here the use of a viral genetic system that allows for cell-type-specific deletion of a viral gene that is essential for replication and reactivation. We employ this system in an in vivo model to reveal that viral replication is not required to initiate or maintain infection within B cells.

Entities:  

Keywords:  B cell; MHV68; ORF50; RTA; chronic infection; gammaherpesvirus; latency; lytic replication; reactivation

Mesh:

Substances:

Year:  2022        PMID: 35647668      PMCID: PMC9215232          DOI: 10.1128/jvi.00690-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  84 in total

1.  Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency.

Authors:  Janice M Moser; Jason W Upton; Kathleen S Gray; Samuel H Speck
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle.

Authors:  James A Stahl; Clinton R Paden; Shweta S Chavan; Veronica MacLeod; Ricky D Edmondson; Samuel H Speck; J Craig Forrest
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

3.  Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome.

Authors:  H Adler; M Messerle; M Wagner; U H Koszinowski
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication.

Authors:  Xiaonan Dong; Hao Feng; Qinmiao Sun; Haiyan Li; Ting-Ting Wu; Ren Sun; Scott A Tibbetts; Zhijian J Chen; Pinghui Feng
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

5.  Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.

Authors:  N P Sunil-Chandra; J Arno; J Fazakerley; A A Nash
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

6.  A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread.

Authors:  Bruno Frederico; Brittany Chao; Janet S May; Gabrielle T Belz; Philip G Stevenson
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

7.  Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo.

Authors:  Christopher M Collins; Samuel H Speck
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

8.  Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency.

Authors:  Laurie T Krug; Janice M Moser; Shelley M Dickerson; Samuel H Speck
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

Review 9.  Epstein-Barr virus latent genes.

Authors:  Myung-Soo Kang; Elliott Kieff
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

10.  Gammaherpesvirus Colonization of the Spleen Requires Lytic Replication in B Cells.

Authors:  Clara Lawler; Marta Pires de Miranda; Janet May; Orry Wyer; J Pedro Simas; Philip G Stevenson
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.